One-year psychophysical evaluation of COVID-19-induced olfactory disorders: a prospective cohort study

Abstract

BackgroundOlfactory disorders are common in COVID-19. While many patients recover within weeks, a notable number of patients suffer from prolonged olfactory disorders. Much research has focused on the acute phase of olfactory disorders in COVID-19; however, there is still inconsistency regarding the prognosis. We aim to assess both objective and subjective olfactory function in patients with persisting olfactory disorders following COVID-19, 1 year after diagnosis.MethodsWe objectively measured olfactory function in 77 patients who initially had COVID-19-induced smell disorders, 1 year after confirmed diagnosis. These patients previously underwent two objective measurements at approximately 3 and 6 months after COVID-19, in the context of the COCOS trial (COrticosteroids for COvid-19-induced loss of Smell). The main outcome measurement was TDI score (threshold-discrimination-identification) on Sniffin’ Sticks Test (SST). Secondary outcomes included objective gustatory function on Taste Strip Test (TST), self-reported olfactory, gustatory and trigeminal function on a visual analogue scale (VAS) and outcomes on questionnaires about quality of life, and nasal symptoms.ResultsThe findings of this study show that 1 year following COVID-19, the median TDI score increased to 30.75 (IQR 27.38–33.5), regarded as normosmia. The median TDI score started at 21.25 (IQR 18.25–24.75) at baseline and increased to 27.5 (IQR 23.63–30.0) at 6 months following COVID-19. The increase of 9.5 points on the TDI score between baseline and 1 year after COVID-19 marks a clinically relevant improvement. Regarding the self-reported VAS score (1–10) on sense of smell, it increased from 1.2 (IQR 0.4–3.0) at baseline to 3.2 (IQR 1.4–6.0) at 6 months and further improved up to 6.1 (IQR 2.7–7.5) after 1 year. Objective gustatory function increased with 2 points on TST a year after diagnosis. Self-reported olfactory, gustatory, and trigeminal functions also improved over time, as did quality of life.ConclusionsObjective and self-reported olfactory function continued to improve 1 year after COVID-19. The median TDI score of 30.75 (IQR 27.38–33.5) is regarded as normosmia, which is a favorable outcome. However, the rate of improvement on TDI score reduces over time.